{"id":"W3112812421","doi":"10.1016/s2152-2650(20)30993-9","title":"MPN-149: Long-Term Safety of Momelotinib in JAK Inhibitor-Naïve and Previously JAK Inhibitor-Treated Intermediate-/High-Risk Myelofibrosis Patients","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sierra Wireless (Canada)","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Anemia; Randomized controlled trial; Gastroenterology; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007048075,0.0002194078,0.000552322,0.0001925897,0.000269043,0.0006738443,0.0003069903,0.000382425,0.00148704],"category_scores_gemma":[0.001217373,0.0001135874,0.0005295456,0.0001932637,0.0002030617,0.0005728031,0.0002197352,0.000931619,0.0002267457],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005324155,"about_ca_system_score_gemma":0.0004467813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005218093,"about_ca_topic_score_gemma":0.001348514,"domain_scores_codex":[0.9997019,0.00008342964,0.00002529199,0.00006633385,0.00006385046,0.00005912269],"domain_scores_gemma":[0.9995381,0.0001063469,0.0001572671,0.00003165386,0.00002753748,0.0001391366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2916692,0.005092087,0.302393,0.0005538657,0.00275608,0.00131233,0.0002843771,0.002337433,0.03188655,0.0004957525,0.004158008,0.3570614],"study_design_scores_gemma":[0.02126708,0.09997923,0.8505341,0.0001769588,0.002584276,0.003314275,0.0002629842,0.004429185,0.008224749,0.0008212674,0.008319335,0.00008642971],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954071,0.002691699,0.0001106481,0.000151915,0.00002908672,0.0000310086,0.0004265308,0.00001635776,0.001135764],"genre_scores_gemma":[0.9980972,0.0004703243,0.00009259579,0.0001453671,0.0000506254,0.00002194202,0.0007325666,0.00000365188,0.0003857488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00148704,"threshold_uncertainty_score":0.004974663,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01922071924019847,"score_gpt":0.2841758719958677,"score_spread":0.2649551527556693,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}